Whilst often discussed alongside GLP-1 receptor agonists such as semaglutide and liraglutide, Mounjaro is technically a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
This combined approach diminishes cravings, prolongs digestion, and improves blood sugar control, ensuring more effective communication with the brains satisfaction centers
Without adequate protein to signal muscle preservation, the body takes both
The DEA schedules substances based on accepted medical use, documented abuse potential, and the risk of physical or psychological dependence developing in users
How does Vyvanse treat binge eating disorder
We can prescribe anti-emetics for nausea to improve appetite